Clinically-engineered intimate solution featuring ExoSCRT® Exosome Complex with 11-step purification technology. Contains 98.7% pure exosomes clinically shown to enhance skin elasticity by 42% and reduce dryness by 67% in 28-day trials. Formulated under ISO 22716:2007 standards for premium feminine care.

Proprietary Exosome Technology:
• Dual-filtration system removes 99.3% impurities
• 40-100nm nanoparticle delivery system
• 2.5x higher bioavailability than standard formulations
• Patent No. US 10,800,765 B2 certified

Sterile Twin-Vial System:
• Vial 1: 500mg Lyophilized Powder (ExoSCRT® Complex)
• Vial 2: 5ml Activation Solution (pH 3.5-4.2)
• Medical-grade PP/PETG packaging
• NFC-enabled anti-counterfeit seal

Clinical Application Protocol:
1. Sanitize treatment area with mild cleanser
2. Combine vial contents using aseptic technique
3. Apply 0.25ml solution per application zone
4. Allow 90sec absorption before dressing
5. Optimal usage: 2x daily for 6-week cycle

*Results may vary based on individual physiology. Contains bioactive components – consult gynecologist before use if pregnant or immunocompromised. Clinical data based on 2023 multicenter trial (n=287). Not intended to diagnose/treat medical conditions.